A Study of Fluzoparib in Combination With mFOLFIRINOX in Patients With Advanced Pancreatic Cancer

NCT04228601 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Pancreatic Cancer

Interventions

DRUG: Fluzoparib
DRUG: Fluzoparib placebo
DRUG: mFOLFIRINOX

Sponsor

Jiangsu HengRui Medicine Co., Ltd.